GlassScriptPhysician profile
Forrest Saunders
NPI 1942717285
$4,727.96
in general payments reported to CMS, 2019-2025
26 companies · $1,465 in 2025
The $1,465 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $654 · 2022: $795 · 2023: $923 · 2024: $891 · 2025: $1,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,279.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,408.20 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Abbott Laboratories | $618.34 | 2021-2025 | Proclaim, Eterna |
| Nevro Corp. | $265.34 | 2022-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255.70 | 2021-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $198.53 | 2021-2023 | Ztlido |
| Abbvie INC. | $134.34 | 2021-2023 | |
| Globus Medical, INC. | $130.42 | 2025 | Senza, Vyrsa V1 |
| Mml US, INC. | $121.69 | 2025 | Reactiv8 |
| Grt US Holding, INC. | $93.35 | 2022 | |
| Curonix LLC | $79.66 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $69.91 | 2023-2025 | Movantik |
| Kowa Pharmaceuticals America, INC. | $47.70 | 2022-2023 | Seglentis |
| Hikma Pharmaceuticals USA | $34.69 | 2022 | |
| Relievant Medsystems, INC. | $27.93 | 2023 | Intracept |
| Convatec INC. | $27.42 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $27.37 | 2025 | |
| Protega Pharmaceutials INC | $24.24 | 2022 | |
| Vertos Medical, INC. | $22.94 | 2023 | Mild Device Kit |
| Redhill Biopharma INC. | $20.06 | 2022 | |
| Biodelivery Sciences International, INC. | $19.75 | 2021 | |
| Stimwave Technologies Incorporated | $18.78 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.94 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.94 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.00 | 2023 | Horizant |
| Almatica Pharma LLC | $15.47 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forrest Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.